Virology, pathogenesis, epidemiology and clinical management of HTLV-1 infection. Proceedings of the 30th HTLV European research network (HERN 2023)
De Mendoza C, Taylor G, Gessain A, Thoma-Kreß A, Bangham C, Vesterbacka J, Accolla R, Bazarbachi A, Van Weyenbergh J, Cook L, Casseb J, Ramos JC, Rosadas C, Macchi B, Cassar O, Soriano V (2024)
Publication Language: English
Publication Type: Journal article
Publication year: 2024
Journal
Book Volume: 3
Pages Range: 61-69
Journal Issue: 1
Abstract
The 30th workshop of the HTLV European Research Network (HERN) was held in Madrid on September 15-16, 2023. Over fifty researchers from Europe and America convened for a two-day conference to update and discuss basic science, epidemiology, clinical management and therapeutics for patients with HTLV-1 infection. Scientific topics addressed included new estimates for HTLV-1 in Europe; impact of antenatal screening on mother-to-child HTLV-1 infections; new insights into the molecular epidemiology of HTLV-1; reports of elite controllers for HTLV-1 infection; role of antiretrovirals as HTLV-1 pre-exposure prophylaxis; and prospects for a HTLV-1 vaccine. The group agreed to submit a formal request to WHO for increasing the global surveillance and awareness of HTLV-1. This viral infection is a potentially life-threatening, neglected condition with neither treatment nor vaccine. At this time, expanding HTLV-1 screening is the most effective way to reduce viral dissemination.
Authors with CRIS profile
Involved external institutions
Institut Pasteur
France (FR)
Universidad Internacional de La Rioja (UNIR) / International University of La Rioja
Spain (ES)
Università degli Studi di Roma 'Tor Vergata'
Italy (IT)
Hospital Universitario Puerta de Hierro - Majadahonda
Spain (ES)
Imperial College London / The Imperial College of Science, Technology and Medicine
United Kingdom (GB)
Karolinska University Hospital / Karolinska Universitetssjukhuset
Sweden (SE)
University of Insubria / Università degli Studi dell'Insubria
Italy (IT)
Rega Institute for Medical Research
Belgium (BE)
University of São Paulo / Universidade de São Paulo (USP)
Brazil (BR)
American University of Beirut (AUB) / الجامعة الأميركية في بيروت
Lebanon (LB)
University of Miami
United States (USA) (US)
France (FR)
Universidad Internacional de La Rioja (UNIR) / International University of La Rioja
Spain (ES)
Università degli Studi di Roma 'Tor Vergata'
Italy (IT)
Hospital Universitario Puerta de Hierro - Majadahonda
Spain (ES)
Imperial College London / The Imperial College of Science, Technology and Medicine
United Kingdom (GB)
Karolinska University Hospital / Karolinska Universitetssjukhuset
Sweden (SE)
University of Insubria / Università degli Studi dell'Insubria
Italy (IT)
Rega Institute for Medical Research
Belgium (BE)
University of São Paulo / Universidade de São Paulo (USP)
Brazil (BR)
American University of Beirut (AUB) / الجامعة الأميركية في بيروت
Lebanon (LB)
University of Miami
United States (USA) (US)
How to cite
APA:
De Mendoza, C., Taylor, G., Gessain, A., Thoma-Kreß, A., Bangham, C., Vesterbacka, J.,... Soriano, V. (2024). Virology, pathogenesis, epidemiology and clinical management of HTLV-1 infection. Proceedings of the 30th HTLV European research network (HERN 2023). NeuroImmune Pharmacology and Therapeutics, 3(1), 61-69. https://dx.doi.org/10.1515/nipt-2023-0025
MLA:
De Mendoza, Carmen, et al. "Virology, pathogenesis, epidemiology and clinical management of HTLV-1 infection. Proceedings of the 30th HTLV European research network (HERN 2023)." NeuroImmune Pharmacology and Therapeutics 3.1 (2024): 61-69.
BibTeX: Download